Caregiver stands behind a stroke patient
Drug Treatment
There is only one approved drug treatment for acute ischemic stroke: tissue plasminogen activator (rtPA) is given via intravenous therapy (IV) and works by dissolving the clot and restoring blood flow to the part of the brain being deprived of blood flow. For safety reasons rtPA is given within 4.5 hours post-stroke.
Mechanical Devices (thrombectomy)
A surgeon inserts the mechanical device via a catheter into the blocked artery. Once inside, the tool traps and removes the clot out of the brain and reopens the blocked blood vessel.
Cerebrolysin®
Cerebrolysin® shall be already used in the acute phase after stroke. It reduces the further death of neuronal tissue and accelerate the healing process in the early stages.
In case of haemorrhagic stroke, the first steps are to find the cause of bleeding in the brain and then to control it. Some of the options for treatments include:
  • Surgical clips
  • Coils inserted in aneurysms
  • Surgery to remove the bleeding vessel and
    blood that has spilled into the brain
  • Hemicraniectomy to reduce Intercranial Pressure (ICP)

Clinical Efficacy in Stroke

The efficacy and safety of Cerebrolysin® in stroke has been assessed in many randomized, double-blind studies.
Learn more

FAQ

Any further questions? Then you can find here some frequently asked questions with detailed answers.
Learn more

Source

https://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf
https://www.world-stroke.org/assets/downloads/WSo_Global_Stroke_fact_Sheet.pdf
https://www.ninds.nih.gov/disorders/stroke/stroke.htm
MARKUS, Hugh S. Stroke: causes and clinical features. Medicine, 2004, 32. Jg., Nr. 10, S. 57-61.
Knecht, Stefan, Stefan Hesse, and Peter Oster. “Rehabilitation nach Schlaganfall.” Deutsches Ärzteblatt, Jg 108 (2011).

Notice to U.S. Visitors

Please be advised that Cerebrolysin is not registered with the U.S. Food and Drug Administration (FDA) and is not approved for sale or distribution in the United States.

Cerebrolysin is a prescription medication for use under the supervision of an authorized health care professional. For any medical inquiries, please consult with a healthcare professional.